Advent Pharma Ltd. (DSE:ADVENT)

CTI BioPharma Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	1,378	2,384	2,459	2,338	2,274	1,893
Market Cap Growth	-38.17%	-3.03%	5.18%	2.82%	20.13%	-25.58%
Enterprise Value	1,449	2,456	2,530	2,392	2,285	1,887
Last Close Price	14.80	25.44	26.00	24.50	23.65	19.69
PE Ratio	28.31	28.39	24.93	23.97	20.02	16.17
PS Ratio	2.88	4.17	4.41	4.41	4.51	3.54
PB Ratio	0.91	1.62	1.76	1.78	1.84	1.69
P/TBV Ratio	0.91	1.62	1.76	1.78	1.84	1.69
P/FCF Ratio	62.35	182.32	958.68	-	-	-
P/OCF Ratio	14.26	13.61	11.98	13.02	12.60	11.13
EV/Sales Ratio	3.03	4.30	4.53	4.51	4.54	3.53
EV/EBITDA Ratio	9.07	11.83	13.05	13.66	13.09	10.01
EV/EBIT Ratio	15.11	17.34	18.69	17.93	16.75	12.14
EV/FCF Ratio	65.56	187.80	986.61	-	-	-
Debt / Equity Ratio	0.05	0.05	0.05	0.05	0.05	0.04
Debt / EBITDA Ratio	0.47	0.37	0.37	0.36	0.34	0.26
Debt / FCF Ratio	3.37	5.81	27.92	-	-	-
Asset Turnover	0.25	0.31	0.33	0.34	0.35	0.41
Inventory Turnover	4.14	4.68	4.16	3.96	4.01	4.43
Quick Ratio	0.94	0.78	0.62	0.71	1.03	1.24
Current Ratio	1.49	1.28	1.15	1.38	1.72	2.01
Return on Equity (ROE)	3.26%	5.85%	7.27%	7.66%	9.65%	10.94%
Return on Assets (ROA)	3.15%	4.86%	4.93%	5.27%	5.90%	7.53%
Return on Capital (ROIC)	3.82%	5.87%	5.94%	6.24%	6.92%	8.74%
Return on Capital Employed (ROCE)	5.60%	8.50%	8.60%	9.00%	10.00%	12.50%
Earnings Yield	3.53%	3.52%	4.01%	4.17%	5.00%	6.19%
FCF Yield	1.60%	0.55%	0.10%	-0.49%	-0.16%	-2.24%
Dividend Yield	0.68%	0.39%	0.77%	0.82%	0.83%	-
Payout Ratio	30.31%	9.76%	8.93%	22.79%	7.11%	7.44%
Total Shareholder Return	0.67%	0.39%	0.77%	0.82%	0.83%	-

Updated Nov 16, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.